Copyright
©The Author(s) 2026.
World J Gastroenterol. Feb 7, 2026; 32(5): 113693
Published online Feb 7, 2026. doi: 10.3748/wjg.v32.i5.113693
Published online Feb 7, 2026. doi: 10.3748/wjg.v32.i5.113693
Figure 1 PRISMA diagram of studies evaluated, excluded, and included in the meta-analysis.
HCC: Hepatocellular carcinoma; M2BPGi: Mac-2 binding protein glycosylation isomer.
Figure 2 Forest plot of hazard ratio for recurrence free survival with weighted means.
A: Univariate hazard ratio (HR) for recurrence free survival (RFS) with weighted means; B: Multivariate HR for RFS with weighted means. HR: Hazard ratio; M2BPGi: Mac-2 binding protein glycosylation isomer.
Figure 3 Hazard ratio funnel plot.
A: Univariate hazard ratio (HR) funnel plot; B: Multivariate HR funnel plot.
- Citation: Stephens KR, Wilson M, Xu M, Gaskins JT, Genova G, Martin II RCG. Mac-2 binding protein glycosylation isomer as a novel serum biomarker for recurrence in hepatocellular carcinoma. World J Gastroenterol 2026; 32(5): 113693
- URL: https://www.wjgnet.com/1007-9327/full/v32/i5/113693.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i5.113693
